- Home
- URG vs LXRX Comparison
URG vs LXRX Comparison
Compare URG & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | URG | LXRX |
|---|---|---|
| Founded | 2004 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 477.8M | 541.5M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | URG | LXRX |
|---|---|---|
| Price | $1.25 | $1.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $2.52 | ★ $3.23 |
| AVG Volume (30 Days) | ★ 9.9M | 1.5M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $39,411,000.00 | ★ $70,864,000.00 |
| Revenue This Year | N/A | $56.61 |
| Revenue Next Year | $183.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 138.94 | ★ 1255.21 |
| 52 Week Low | $0.55 | $0.28 |
| 52 Week High | $2.35 | $1.66 |
Technical Indicators
Market Signals| Indicator | URG | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.24 | 45.46 |
| Support Level | $1.17 | $1.29 |
| Resistance Level | $1.46 | $1.48 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 27.62 | 23.70 |
Price Performance
Historical ComparisonAbout URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.